Skip to main content

Cancers of the Head and Neck

  • Chapter
  • 255 Accesses

Abstract

Head and neck cancers comprise about 5% of all cancers worldwide. Because of the complex normal head and neck anatomy, which is further altered after surgical or radiation treatment, PET imaging of glycolysis has contributed to the diagnostic work-up of these patients. However, physiological muscle activity, vocal cord and normal thyroid activity can render the interpretation of molecular images difficult. PET/CT has helped to overcome some of these difficulties and it was this indication for which the usefulness of PET/CT was first tested and established using the prototype PET/CT at the University of Pittsburg.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  • Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, Juillard G, Maddahi J, Phelps ME. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer. 1994;73(12):3047–3058.

    Article  PubMed  CAS  Google Scholar 

  • Grünwald F, Menzel C, Bender H, Palmedo H, Willkomm P, Ruhlmann J, Franckson T, Biersack HJ. Comparison of 18FDG-PET with 131Iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid. 1997;7(3):327–335.

    Article  PubMed  Google Scholar 

  • Lowe VJ, Dunphy FR, Varvares M, Kim H, Wittry M, Dunphy CH, Dunleavy T, McDonough E, Minster J, Fletcher JW, Boyd JH. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18] fluorodeoxyglucose positron emission tomography. Head Neck. 1997;19(8):666–674.

    Article  PubMed  CAS  Google Scholar 

  • Altenvoerde G, Lerch H, Kuweit T, Matheja P, Schäfers M, Schober O. Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans. Langenbecks Arch Surg. 1998;383(2):160–163.

    PubMed  CAS  Google Scholar 

  • Schlüter B, Grimm-Riepe C, Beyer W, Lübeck M, Schirren-Bumann K, Clausen M. Histological verification of positive fluorine-18 fluorodexoyglucose findings in patients with differentiated thyroid cancer. Langenbecks Arch Surg. 1998;383(2):187–189.

    PubMed  Google Scholar 

  • Adam S, Baum RP, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25(9): 1255–1260.

    Article  Google Scholar 

  • Wang W, Macapinlac H, Larson SM, Yeh SD, Akhurst T, Finn RD, Rosai J, Robbins RJ. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab. 1999;84(7):2291–2302.

    Article  PubMed  CAS  Google Scholar 

  • Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid. 1999;9(8):797–804.

    Article  PubMed  CAS  Google Scholar 

  • Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Radiology. 1999;212(3):799–802.

    PubMed  CAS  Google Scholar 

  • Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack HJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med. 1999;26(12): 1547–1552.

    Article  PubMed  Google Scholar 

  • Hubner KF, Thie JA, Smith GT, Chan AC, Fernandez PS, McCoy JM. Clinical utility of FDG-PET in detecting head and neck tumors: a comparison of diagnostic methods and modalities. Clin Positron Imaging. 2000;3(1):7–16.

    Article  PubMed  Google Scholar 

  • Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, Martin D, Stack BC Jr, Hollenbeak C, Fletcher JW. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000; 18(3):651–658.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Czernin, J., Dahlbom, M., Ratib, O., Schiepers, C. (2004). Cancers of the Head and Neck. In: Atlas of PET/CT Imaging in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18517-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18517-5_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62141-3

  • Online ISBN: 978-3-642-18517-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics